Literature DB >> 8983207

Molten globule intermediate of recombinant human growth hormone: stabilization with surfactants.

N B Bam1, J L Cleland, T W Randolph.   

Abstract

We demonstrate that a surfactant-stabilized molten globule intermediate exists for recombinant human growth hormone (rhGH), is very hydrophobic, and tends to form aggregates. Characterization of this intermediate included equilibrium denaturation measured by electron paramagnetic resonance (EPR) and CD spectroscopy, assessment of aggregation during refolding, and fluorescence studies of its binding to the hydrophobic probe, 1-anilinonapthalene-8-sulfonate (1,8-ANS). We have found that at 4.5 M guanidinium hydrochloride (GuHCl), a molten globule intermediate of rhGH is stabilized and results in significant aggregation upon refolding. This intermediate is populated by the addition of the nonionic surfactant, Tween. This surfactant also reduces the extent of aggregation during refolding of rhGH from 4.5 M GuHCl. Overall, our studies reveal that rhGH forms a molten globule-like intermediate during folding and this intermediate self-associates. This self-association is reduced upon formation of a Tween-rhGH complex. Tween also binds to the native protein. Thus, nonionic surfactants such as Tween may act like molecular chaperones in facilitating protein folding while not altering the native conformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8983207     DOI: 10.1021/bp960068b

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  15 in total

1.  Inverse relationship of protein concentration and aggregation.

Authors:  Michael J Treuheit; Andrew A Kosky; David N Brems
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  High pressure fosters protein refolding from aggregates at high concentrations.

Authors:  R J St John; J F Carpenter; T W Randolph
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 3.  Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Theodore W Randolph; John F Carpenter
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

4.  Displacement of adsorbed insulin by Tween 80 monitored using total internal reflection fluorescence and ellipsometry.

Authors:  S H Mollmann; U Elofsson; J T Bukrinsky; S Frokjaer
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

Review 5.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

6.  Effect of polysorbate 80 quality on photostability of a monoclonal antibody.

Authors:  Swita R Singh; Jingming Zhang; Courtney O'Dell; Ming-Ching Hsieh; Joel Goldstein; Joseph Liu; Arvind Srivastava
Journal:  AAPS PharmSciTech       Date:  2012-02-24       Impact factor: 3.246

7.  Experimental Model System to Study pH Shift-Induced Aggregation of Monoclonal Antibodies Under Controlled Conditions.

Authors:  Olubukayo-Opeyemi Oyetayo; Hans Kiefer
Journal:  Pharm Res       Date:  2016-02-29       Impact factor: 4.200

8.  Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.

Authors:  Surinder M Singh; Swati Bandi; David N M Jones; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2017-08-24       Impact factor: 3.534

9.  Effect of polysorbate 80 concentration on thermal and photostability of a monoclonal antibody.

Authors:  Meera Agarkhed; Courtney O'Dell; Ming-Ching Hsieh; Jingming Zhang; Joel Goldstein; Arvind Srivastava
Journal:  AAPS PharmSciTech       Date:  2012-11-14       Impact factor: 3.246

10.  Thermodynamic characterization of an intermediate state of human growth hormone.

Authors:  I Gomez-Orellana; B Variano; J Miura-Fraboni; S Milstein; D R Paton
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.